Unsanitized: We’ve Given Almost Nothing to States and Cities for Vaccine Distribution

This breakthrough relies on rickety, underfunded local health systems. This is The COVID-19 Daily Report for November 23, 2020.

by

First Response

The day that the COVID-19 vaccines are approved for emergency use by the FDA—likely December 11, based on the timing of their meetings—will be a great triumph for science and public investment. The Moderna and Pfizer vaccines, for the first time based on messenger RNA, herald a new scientific breakthrough that could unlock a host of new therapies and palliatives. (AstraZeneca’s vaccine, which announced some positive results today, could also be approved in short order.) And the rapid timing from discovery of the virus to a vaccine, pushed along by public dollars and guarantees, should also become a model, though if we collaborated with the world instead of going it alone we would have dispensed the vaccine even faster and saved a lot of lives.

But these innovations, which will have wide-ranging effects into the future, collide with the near-term block and tackle of how you get a drug manufactured, stored, and shipped to every corner of the globe, to be administered, twice, to virtually everyone on the planet. At some point the science gives way to a logistics operation on a scale nobody has ever seen before. Compounding this difficulty is the fact that Joe Biden’s transition has no access to the vaccine data and is frozen out from the decision-making process.

The infrastructure we currently have for vaccine distribution is by definition weak, because the scale of what’s needed with this is so massive. The Vaccine for Children program provides something like 3 million shots a year. We need 600 million in a matter of a few months, just for the U.S. And the big, glaring problem is that, in our federal system, the primary role in actually getting the vaccine delivered to people goes to states and localities. And incredibly, there’s practically no money for this purpose right now.

Read all of our Unsanitized reports

Here is how this has been explained to me. There are 64 “jurisdictional immunization programs,” which includes 50 states, D.C., eight U.S. territories, and five large cities. They ask for an allocation and the government, through Operation Warp Speed, will fill that. But at that point it’s up to the jurisdictions to determine vaccination sites, transport the vaccine to those locations, and make sure there’s enough demand at each particular site so the vaccine doesn’t go to waste. Pfizer’s vaccine in particular has a short shelf life, just five days in a refrigerator, so it has to get out immediately once it reaches the last leg of the journey.

There’s also prioritization for who gets the initial supply of shots, staffing for how administers them and how the health system can integrate it, and just a mountain of other details. We already know about the freezers; many locations just don’t have this capability.

So how much money has been allocated for this, the largest logistical project in the history of mankind? $200 million. That’s all the jurisdictions have received thus far. Biden has promised $25 billion for vaccine distribution, but that’s tied up in the moribund stimulus talks. There may be some smart person devising some way to unlock emergency funding along the lines of what Trump did on the border wall, but at the moment, you need Congress to issue some dollars. “[W]e absolutely do not have enough to pull this off successfully,” said the state health officer of Mississippi to the New York Times.

This is absolute madness. The economic and public health effects of efficient delivery of a vaccine are almost incalculable. It will unleash pent-up demand across the country and return the country to something resembling normalcy. This multi-trillion-dollar, multi-tens-of-thousand-life action is resting on a couple hundred million distributed across the country? What?

This case study of preparations in my home county, Los Angeles, is instructive. They’ve bought the ultra-cold freezers, which is more than a lot of places can manage. But there aren’t any plans on how to ship the vaccine from one freezer to another. The decisions on where to distribute the vaccine haven’t been made. All of these decisions cost money, and making the wrong one and having to change plans cost more money. That money doesn’t exist without federal assistance.

As Olivia Webb reports, with states largely unable to act, HHS is going through CVS and Walgreens to deliver to long-term care facilities. Other large chain pharmacy partnerships are being put in motion. Distribution, in other words, is being privatized. “There are huge potential failure points,” Webb notes, common to the idea that scale can magnify disruptions. If one of the thousands of little nodes in the jurisdictions have a refrigeration problem, that can be managed with some other part of the network. If CVS fails, that could affect a much larger population.

Of course, this is just the national response. Global vaccine distribution is a whole other can of worms, one that’s incredibly necessary to prevent future outbreaks and mutations. There’s a global consortium called Covax that is dedicated to this task, but this Times takeout on Bill Gates’ role with the organization and the use of a bunch of McKinsey consultants is not very satisfying. In particular, the lingering effects of drug company intellectual property fights hangs over the whole enterprise.

In the immediate term, cities and states have to have the funding to distribute the vaccine. Otherwise, this gets wrapped up with big business in ways that could have disastrous effects on global health.

Look at Me

I was on Dead Pundits Society talking about the Day One Agenda. Listen here.

I was on The Intercept’s Deconstructed podcast, also talking about the Day One Agenda. Listen here.

Days Without a Bailout Oversight Chair

241.

Today I Learned

Unlike many news organizations, the Prospect has remained staunchly committed to keeping our journalism free and accessible to all. We believe that independent journalism is crucial for a functioning democracy—but quality reporting comes at a cost.

This year, we’re aiming to raise $75,000 to continue delivering the hard-hitting investigative journalism you’ve come to expect from us. Your support helps us maintain our independence and dig deeper into the stories that matter most.

If you value our reporting, please consider making a contribution today. Any amount helps secure our future and ensure we can continue holding power to account.

Will you support independent journalism with a donation to the Prospect?